Brevan Howard Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Brevan Howard Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$747K	Buy
2025 Q1	–	Sell
2024 Q4	$1.04M	Buy
2024 Q3	$207K	Sell
2024 Q2	$542K	Sell
2024 Q1	$626K	Buy
2023 Q4	$558K	Buy